Comment on page
MAlaria Inhibitor Prediction platform
The malaria inhibitor prediction (MAIP) platform is the result of a public-private collaboration whose aim is to develop a consensus model for predicting blood stage malaria inhibition. Five Pharma and not-for-profit partners trained a model (using code developed by EMBL-EBI) on their private datasets. The resulting models were combined by EMBL-EBI and made available through this public prediction platform.
The work to create MAIP is described in full in an article. Note: the fingerprints described in the manuscript and in MAIP slightly differ; the ones in the publication keep the feature frequencies while the ones currently implemented don't.